Albemarle (ALB) Q3 2026 earnings review
Albemarle raises its bromine plan, but lithium margins shrink
Albemarle, a major lithium and bromine producer, earned much more than a year ago while its quarterly margins shrank. Ongoing segment sales jumped 43% as lithium prices nearly doubled from last year's trough, and third-quarter Specialties profit finished well above what the company's own plan pointed to. Chief executive Kent Masters raised the Specialties outlook again, but costlier raw lithium ore squeezed margins and the unchanged company plan leaves fourth-quarter profit falling almost in half to about $333 million by our math.
| Sales from ongoing segments | +43% total revenue +19% from a year ago (includes sold Ketjen unit in base) |
|---|---|
| Profit per share, excluding one-offs | $2.58 loss of $0.19 a year ago |
| Energy Storage EBITDA margin | 50.0% 56.7% last quarter |
| Specialties full-year profit outlook | Raised $62.5M middle of the range: $362.5M |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because improvements in bromine and cost cuts merely offset a deeper margin squeeze in lithium. Reaching the $150 million cost-savings goal early and raising the Specialties plan for a third time are real gains, but beating the old bromine target mainly shows that plan was cautious. On the other side, Albemarle cut its capital budget to $300–350 million by delaying early-stage projects and kept its total profit outlook flat, which means lithium margins are dropping faster than the bromine raise adds.
The question now is whether fourth-quarter lithium profit is just working through a temporary lag in ore costs or resetting to a lower level while delayed projects cap future volume growth. Either margins rebound once the costlier ore inventory clears, or lower spot prices and flat volumes keep earnings down. Fourth-quarter Energy Storage margins and the 2027 volume plan will tell.
🐂 Bull Case
Specialties Profit Prompted a Third Outlook Raise
"In Specialties, improved pricing and sustained progress on cost and productivity initiatives support an additional increased outlook for the year," chief executive Kent Masters said. This division sells bromine used in electronics, oilfield work and fire safety. Three months ago, the full-year outlook pointed to $41–66 million of quarterly division profit before interest, taxes, depreciation and amortization (EBITDA), excluding one-offs, by our math.
The division earned $98.7 million in the third quarter, up 31% from a year ago, as prices rose 10% and volumes grew 3%. Its Jordan Bromine Company joint venture also hit record quarterly output and offset Middle East shipping costs through "proactive management of cost escalations driven by the conflict in the Middle East". That beat says the prior plan was cautious, so Albemarle raised the division's full-year target by $62.5 million at the middle of the range.
What to watch: fourth-quarter Specialties EBITDA, which the new plan puts near $70 million by our math. Holding above last year's $68.6 million would show that factory savings are keeping margins up even as bromine prices steady.
Cost Savings Hit the Full-Year Goal Early
Albemarle began the year aiming to cut $100–150 million of annual expenses through manufacturing and supply-chain changes. By September, the chemical maker had delivered more than $150 million in yearly run-rate savings, "achieving the high end of our full-year target" one quarter early.
Selling, general and administrative overhead fell to 8.8% of sales from 10.6% a year ago, while research spending dropped from $12.7 million to $8.2 million. Reaching the savings goal early matters because it lowers the lithium price the group needs to stay profitable, though it required $11.6 million in third-quarter consulting fees that were excluded from adjusted profit.
What to watch: whether management sets a new 2027 savings target on the fourth-quarter call. A fresh program would show that plant productivity gains can continue without further cuts to research.
Lithium Plant Ramp and Debt Paydown
After a June fire delayed the new Chemical Grade Plant 3 (CGP3) at its Australian Talison lithium joint venture, the facility "achieved 30-days of nameplate performance in September". Meanwhile, early-year debt paydowns and higher earnings cut net debt to 0.3 times annual adjusted EBITDA, down from 2.0 times at the end of 2025. Two other standing drivers were not updated in the release:
- Grid battery demand and lithium inventory levels: global lithium demand rose 48% through August, but the release gave no update on customer inventory weeks or stationary storage's share.
- Atacama direct lithium extraction (a faster brine processing technology in Chile): no third-quarter update on pilot results or permits; the quarterly call or filing is the next check.
What to watch: Energy Storage sales volumes in the fourth quarter, which the full-year plan puts near 56 kilotons of lithium carbonate equivalent (LCE, a standard measure of lithium content) by our math. Hitting that level would confirm CGP3 is running smoothly.
🐻 Bear Case
Costlier Lithium Ore Squeezed Third-Quarter Margins
Albemarle's Energy Storage division mines and refines lithium for electric-vehicle and grid batteries. Realized lithium prices nearly doubled from a year ago to $20.02 per kilogram of LCE, lifting third-quarter division profit by 351% to $560 million. However, because it takes about four months to ship and refine spodumene (raw lithium ore) from Australia, second-quarter ore price increases hit third-quarter costs.
Company-wide cost of goods sold—the cost of mining and refining products—rose by 14.5 percentage points of revenue from the second quarter to 80.6%, pulling gross margin down from 33.9% to 19.4%. Division EBITDA margin dropped by 6.6 percentage points from the prior quarter to 50.0% on "higher price spodumene inventory processed in the quarter and increased Chilean commissions". Management now warns that fourth-quarter sales and margins will fall again from "consumption of higher-cost spodumene inventory purchased in prior periods" and lower lithium prices.
What to watch: fourth-quarter Energy Storage EBITDA, which the $20 lithium price case puts near $365 million by our math. A drop below that level would show that lower spot prices are compounding the ore cost lag.
Project Delays Drove the Capital Spending Cut
"We will continue to prioritize high-return organic growth by leveraging our advantaged resource base, capital spending efficiency, and financial flexibility," Masters said. In the same release, Albemarle cut its 2026 capital spending plan by about $175 million, to $300–350 million, citing capital efficiency and "resequencing of some early-stage projects".
The lithium producer has now lowered its 2026 project budget twice since March, when it planned to spend $550–600 million. Delaying early-stage projects saves cash today, but global lithium demand grew 48% through August while Albemarle's own 2026 sales volume plan sits at 225–235 kilotons, flat to slightly below last year.
What to watch: the 2027 volume and capital budget in the fourth-quarter report. Another year of flat volumes or delayed project approvals would mean rivals capture the industry's demand growth.
Risks this quarter didn't answer
Four standing risks around contracts, idle plants, share dilution and battery chemistry got no new resolution in the release.
- Long-term lithium contracts: still cover "approximately 40% of salts volume (or one-third of total volumes) on long-term agreements", with no update on two major contracts expiring at year-end.
- Western refining costs: keeping Kemerton Train 1 in Australia idle cost another $8.0 million in third-quarter restructuring charges; restart thresholds remain unstated.
- Preferred stock dilution: mandatory convertible preferred stock converts in March 2027; adjusted diluted shares already rose 16.5% from a year ago to 137.1 million.
- Sodium-ion battery competition: no commentary in the release on alternative grid-storage chemistries.
👓 Other Themes
Global Lithium Demand Rose 48% Through August
Global lithium demand rose 48% from a year ago in the first eight months of 2026, Masters said, up from the 45% pace through May, driven by electric vehicles and stationary grid batteries. In Specialties, demand grew modestly in semiconductors, oil and gas, flame retardants and pharmaceuticals, while automotive and petrochemical markets stayed steady despite ongoing Middle East shipping disruptions.
💲 Other KPIs
Cash from operations rose from $356 million a year ago but fell from $710 million in the second quarter. The share of profit that turned into cash dropped to 63% from 83% last quarter as working capital absorbed cash, partly offset by a dividend from the Talison lithium joint venture.
Stockpiles rose 18.1% from the end of 2025, climbing in every quarter this year as costlier lithium ore moved through processing. Over the same nine months, bills owed to joint-venture partners—accounts payable to related parties—more than doubled from $134 million to $330 million.
The share count used to calculate profit per share excluding one-offs rose 16.5% from 117.7 million a year ago. Because Albemarle is now profitable, the count includes the assumed conversion of $2.24 billion in mandatory convertible preferred stock, which saves $41.7 million in quarterly preferred dividends.
🔮 Guidance
Unchanged. Under the $20 lithium price case, the middle of the range points to 13.8% full-year growth. By our math, that leaves $1.12 billion for the fourth quarter, down 21% from a year ago because last year included the sold Ketjen unit; ongoing segment sales would rise about 3%.
Unchanged. The middle of the range calls for $2.5 billion of full-year profit, more than double last year's $1.10 billion. With $2.17 billion already earned in the first nine months, the plan leaves about $333 million for the fourth quarter by our math, down nearly half from the third quarter's $646 million.
Unchanged. The middle of the range is $4.1 billion, up 51% from last year. By our math, that leaves about $813 million for the fourth quarter, down 27% from the third quarter's $1.12 billion as lower lithium prices flow through contracts.
Unchanged. At the $2.2 billion middle of the range, full-year profit triples from last year's $697 million. After $1.83 billion in the first nine months, the plan leaves $365 million for the fourth quarter by our math, down 35% from the third quarter as costlier ore inventory is used.
Unchanged. This line tracks after-tax profit from joint-venture mines in Australia. Total company equity income reached $453 million in the first nine months, leaving roughly $200 million for the fourth quarter at the middle of the range.
Unchanged. Output from the Wodgina mine continues to offset the June fire delay at Talison's CGP3 plant. With 174 kilotons sold in the first nine months, the middle of the range leaves 56 kilotons for the fourth quarter by our math, matching the third quarter.
Unchanged. After two raises earlier this year, the sales range stayed at $1.5 billion at the middle. With $1.17 billion recorded in the first nine months, the middle of the range leaves $329 million for the fourth quarter by our math, down 15% from the third quarter.
Raised. The middle of the range moved up $62.5 million to $362.5 million, up 31% from last year. It is the third raise in three quarters: +$50M, +$50M, +$62.5M. By our math, that leaves about $70 million for the fourth quarter, vs $98.7 million in Q3.
Cut. Management lowered the middle of the budget by $175 million to $325 million, down 45% from last year's $590 million. It is the second cut this year (0, -$75M, -$175M). With $251 million spent in nine months, that leaves $74 million for Q4 by our math.
Unchanged. This line includes currency effects, the retained catalyst business and equity income from the 49% Ketjen stake. Corporate posted $40.2 million in the first nine months after a $13.0 million third-quarter loss, so the middle of the range implies a $40 million fourth-quarter charge by our math.
Unchanged. Nine-month depreciation and amortization totaled $482 million, including $168 million in the third quarter. Reaching the $670 million middle of the range would require $188 million in the fourth quarter by our math.
Unchanged. Nine-month interest expense was $91.8 million, including $27.8 million in the third quarter after first-quarter debt repayments. By our math, the $130 million middle of the range leaves $38.2 million for the fourth quarter.
Unchanged. The full-year tax rate excluding one-offs stayed in its wide range, which varies with lithium prices and where profits are earned. The rate was 5.8% in the third quarter and 12.0% for the first nine months.
Unchanged. The full-year count assumes the conversion of mandatory convertible preferred stock into common shares. Nine-month adjusted diluted shares averaged 136.5 million.
❓ Key Questions
Which early-stage projects were delayed in the budget cut?
Albemarle cut 2026 capital spending by $175 million at the middle of the range, citing efficiency and "resequencing of some early-stage projects". Naming the delayed projects would show whether 2027–2028 lithium volume growth is affected.
Have the two expiring long-term lithium contracts been renewed?
Long-term contracts still cover about 40% of lithium salts volume, and management previously promised a year-end update on two major expiring deals. Their renewal terms determine how exposed 2027 profit is to spot prices.
How much did receivables sales add to third-quarter cash flow?
Albemarle sold $517 million of customer bills in the first half to speed up cash collection, but the earnings release does not give the third-quarter balance. The quarterly filing will show how much of the $406 million operating cash flow came from factoring.
Why wasn't the $20 lithium profit outlook raised?
Albemarle raised its Specialties profit outlook by $62.5 million and cut capital spending, yet held its total company EBITDA range under the $20 lithium price case unchanged. That implies a weaker fourth quarter in Energy Storage or Corporate.